Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Holly A. Zboyan"'
Autor:
Geetha Shivakumar, Ira H. Bernstein, Robert Gonzalez, Lauren B. Marangell, Diane Snow, Melissa Martinez, E. Grace Fischer, Suresh Sureddi, Trisha Suppes, Dorothy I. Kelly, Rayan K. Al Jurdi, Holly A. Zboyan
Publikováno v:
Journal of Affective Disorders. 111:334-343
Treatment studies are lacking for patients with bipolar II disorder (BDII). The objective of this study was to compare lamotrigine (LTG) and lithium (Li) monotherapy for the treatment of BDII depression.Patients with BDII acute depression were random
Autor:
Suresh Sureddi, Grace Fischer, Lauren B. Marangell, John Carson Allen, Sandhya J. Prashad, Diane Snow, Trisha Suppes, Holly A. Zboyan
Publikováno v:
The Journal of Clinical Psychiatry. 69:183-189
OBJECTIVE Vagus nerve stimulation (VNS) appears to be an effective treatment option for patients with treatment-resistant unipolar and bipolar depression. The aim of the present study was to investigate the efficacy of VNS in a group of patients with
Publikováno v:
Current Psychosis & Therapeutics Reports. 4:167-170
Bipolar disorders are prevalent and severe illnesses that are associated with a high risk of suicide. Patients with bipolar disorder who have had prior suicide attempts are at a substantially higher risk for future suicidality, even after controlling
Autor:
James M. Martinez, Stephen R. Wisniewski, Roy H. Perlis, Maria A. Oquendo, Mark S. Bauer, Sachiko Miyahara, Ellen B. Dennehy, Gary S. Sachs, Michael E. Thase, Cheryl A. Chessick, Michael Otto, Ellen Frank, Andrea Fagiolini, Michael H. Allen, Lauren B. Marangell, Holly A. Zboyan, David J. Miklowitz
Publikováno v:
Bipolar Disorders. 8:566-575
Objectives: Bipolar disorders are associated with high rates of suicide attempts (SAs) and completions. Several factors have been reported to be associated with suicide in persons with bipolar disorder, but most studies to date have been retrospectiv
Autor:
Holly A. Zboyan, James M. Martinez
Publikováno v:
CNS Spectrums. 11:143-148
This is the first case report of a patient who received long-term (69-month) adjunctive vagus nerve stimulation (VNS) therapy for treatment-resistant depression (TRD) and reached VNS battery end-of-service (EOS).The patient is a 41-year-old female wi
Autor:
Holly A. Zboyan, James M. Martinez, Christopher R. Johnson, Lauren B. Marangell, Barbara Kertz
Publikováno v:
The Journal of Clinical Psychiatry. 63:391-395
Background: We report a clinical trial of olanzapine in the treatment of prominent apathy in the absence of depression in patients on long-term treatment with selective serotonin reuptake inhibitors (SSRIs) for nonpsychotic major depression. Method:
Publikováno v:
Acta psychiatrica Scandinavica. 116(3)
Objective: In response to an increased understanding of the neurobiology of severe psychiatric disorders, new therapeutic modalities are entering clinical practice that involve the direct stimulation of the brain. Method: We provide a review of publi
Autor:
Ellen B. Dennehy, Terence A. Ketter, Barbara Kertz, Joseph R. Calabrese, Holly A. Zboyan, Gary S. Sachs, Trisha Suppes, Andrew A. Nierenberg, Lauren B. Marangell, Stephen R. Wisniewski
Publikováno v:
Prostaglandins, leukotrienes, and essential fatty acids. 75(4-5)
Several lines of evidence suggest that omega-3 fatty acids may be important in the pathophysiology, treatment or prevention of bipolar disorder (BD). Electronic and manual searches were conducted in order to review the literature relevant to the etio
Publikováno v:
Depression and anxiety. 19(1)
Based on the putative relationship between depleted omega-3 fatty acids and postpartum depression, we initiated an open-label pilot study of omega-3 fatty acid supplementation with the aim of preventing postpartum depression. Euthymic pregnant female
Autor:
Holly A. Zboyan, Lauren B. Marangell, H. Florence Seung Kim, Barbara Kertz, James M. Martinez, Lucy J. Puryear
Publikováno v:
The American journal of psychiatry. 160(5)
OBJECTIVE: This study was an evaluation of the omega-3 fatty acid docosahexaenoic acid (DHA) for the treatment of major depression. METHOD: Thirty-six depressed patients were randomly assigned to receive DHA, 2 g/day, or placebo for 6 weeks. Response